1. During the period from 1991 to 2013, the number of prescriptions written for opiates:
A. Doubled
B. Increased 3-fold
C. Dropped by 10%
D. Remained the same
2. When the Drug Enforcement Administration is deciding if a drug should be placed into a schedule, 8 factors must be considered. Which of the following is NOT one of them:
A. The risk of producing physiological dependence
B. If the substance is a precursor of an already listed drug
C. If the drug is sold over the Internet
D. The drug's history and pattern of abuse
3. Who may request that a drug be placed on the list of controlled substances?
A. Only the Drug Enforcement Administration (DEA) may initiate a request
B. The DEA or the U.S. Food and Drug Administration (FDA) may initiate a request
C. The DEA or a law enforcement official may initiate a request
D. Any interested party may initiate a request
4. The compounds listed in the Drug Enforcement Administration (DEA) published schedules:
A. Fall into 5 different schedules
B. Are considered to be comprehensive and complete lists of controlled substances by the DEA
C. Include non-narcotic over-the-counter (OTC) products
D. All of the above
5. When considering if a drug should be scheduled, the Drug Enforcement Administration (DEA) seeks a recommendation from the U.S. Food and Drug Administration (FDA). The FDA recommendation:
A. Is binding on the DEA, if the FDA recommends scheduling
B. Is binding on the DEA, if the FDA concludes it should not be scheduled
C. Is merely advisory and is not binding on the DEA in any way
D. None of the above, because the DEA is not obligated to seek a recommendation from anyone before making a decision
6. Moving hydrocodone combination products from Schedule III to Schedule II:
A. Became effective in 2014
B. Occurred rapidly as the result of timely action by the Drug Enforcement Administration and U.S. Food and Drug Administration
C. Was strongly supported by users of the drug products
D. Occurred shortly after pure hydrocodone was similarly treated
7. In response to pharmacist concerns about added burdens related to upscheduling hydrocodone combination products, the DEA said:
A. It was sympathetic and would reconsider their decision at a future date
B. It did not feel there would be any added burdens
C. Procedures related to dispensing were not relevant factors in their decision making
D. There were no concerns raised by pharmacists about administrative burdens
8. A previously unknown drug has surfaced in your community and its abuse has become a serious problem. The Drug Enforcement Administration:
A. Must go through its usual rulemaking process, which can take up to 1 year before the drug can be considered illegal
B. Must wait for Congress to declare its intent to control the drug
C. May permanently place the drug into Schedule I if there is an immediate threat to public safety
D. May temporarily place the drug in Schedule I if there is an immediate threat to the public safety while it conducts further studies
9. The Drug Enforcement Administration (DEA) decided to place tramadol into Schedule IV because of all of the following reasons, EXCEPT:
A. Tramadol is converted to an active metabolite with affinity for the mu-opioid receptor
B. The DEA concluded that there would be a sufficiently high probability of diversion
C. The DEA was concerned about the overprescribing of this drug in long-term care facilities
D. Law enforcement officials reported a rate of confiscation of tramadol during their activities that was comparable to that of other C-IV drugs
10. Some attribute the rise in heroin abuse to a reduced availability of prescription opiates. Other possible factors responsible for the increase in heroin use include all of the following, EXCEPT:
A. Heroin has become cheaper in the last 2 decades
B. Heroin has become available in purer forms
C. Heroin has become easier to find, especially in suburban areas
D. Heroin is easier to administer as an intravenous injection
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. To what extent did the program meet objective #5?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
23. Will the information presented cause you to change your practice?
A. Yes
B. No
24. Are you committed to making these changes?
A. Yes
B. No
25. As a result of this activity, did you learn something new?
A. Yes
B. No
26. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
27. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20
E. >20